Date updated:01-17-2007
Breakthrough drug opportunities

-
ENCY
Encysive Pharmace - $0.00
- 0.00%
- $N/A
No Analysis added

-
BIVN
Bivn - $0.00
- N/A
- $N/A
No Analysis added

-
DCGN
Decode Genetics - $0.043
- +34.38%
- $0.035
No Analysis added

-
ONCY
Oncolytics Biotec - $2.70
- -3.23%
- $2.76
No Analysis added

-
ELN
Elan Cp Plc Adr - $6.46
- -2.71%
- $6.56
No Analysis added

-
CBRX
Columbia Laborato - $0.95
- +1.93%
- $0.9301
No Analysis added
- Medical Opportunities's Blog
- No Blogs Found
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Navellier & Associ...
- 3. Calamos Advisors
- 4. Argus Management
- 5. Bernard L. Madoff Inve...
- show all
- Top Do-It-Yourself Portfolios
- » Joseph Russell Portfolio 1
- » Albo's First Portfolio
- » Darrell Werth Portfolio 1
- » Echo5Joker's Portfolio
- » jgroov Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
Not a Stockpickr member? Join the community today -- for free.Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about...
By Roberto Pedone Posted on Nov. 20, 2009 According to Jim Cramer, options expiration is driving the current market selloff. He pointed out that the only stocks that we...
By Roberto Pedone Posted on Nov. 19, 2009 According to CNBC’s “Fast Money” traders, the stock market is showing no signs of stopping its current bull run. Joe Ter...
By Jonas Elmerraji Posted on Nov. 18, 2009 There are plenty of reasons for stocks to have the attention of short-sellers. Waning financials, a deteriorating business mo...
A. a sector pair but not an industry pair
AAPL/AMT
A. The only one I own : SLX,
too hard pick a winner out all of them
Here are some of the largest % gainers from Nov. 20, 2009. more
Here are some stocks that moved up on unusual volume on Nov. 19, 2009. more
Here are some of the biggest stocks that made the 52-week high list on Nov. 20, 2009. more











Comments not available